Nifty200 Alpha30 PB	8.3
Nifty200 Alpha30 PE	55.0
Nifty200 Alpha30 DIV	0.4
Nifty200 Alpha30 EPS	457.6

Nifty200 Alpha30 Corporate Filings & Announcements

Latest corporate announcements and filings from Nifty200 Alpha30 on BSE

Load latest

Glenmark Pharmaceuticals Ltd.

14 Aug 2025

1937.30

-0.19%

Board Meeting

Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Outcome of the Board Meeting held on 14th August, 2025

pdf

Glenmark Pharmaceuticals Ltd.

14 Aug 2025

1937.30

-0.19%

Company Update

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find attached Press Release and Management Discussion & Analysis of the Company for the first quarter ended June 30, 2025

pdf

Max Healthcare Institute Ltd.

14 Aug 2025

1234.70

-1.23%

Company Update

Max Healthcare Institute Ltd - 543220 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations …

BSE India

Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Shriram Finance Ltd.

14 Aug 2025

615.85

-0.64%

Company Update

Shriram Finance Ltd - 511218 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, read with Schedule III thereto, this is to inform that Fund/ Analysts/ Institutional Investor/ Broker/Broker Conference /meetings are scheduled to be held on Wednesday, August 20 2025, which will be attended by the senior management/ management personnel of the Company. The discussion will be based on investor update/presentation and public domain disclosures. In accordance with the said Regulation(s), please find below the detail of scheduled meeting with the Fund/ Analyst/ Institutional Investor/ Broker/ Broker Conference etc.at Equirus Annual India Conference.

pdf

Glenmark Pharmaceuticals Ltd.

14 Aug 2025

1937.30

-0.19%

Result

Glenmark Pharmaceuticals Ltd - 532296 - Unaudited Financial Results (Standalone And Consolidated) For The First Quarter …

BSE India

Please find attached herewith Unaudited Financial Results for the first quarter ended 30th June, 2025

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	3290.88	3267.89	3275.68	0.7%	0.5%
Operating Profit Qtr	580.52	561.02	588.21	3.5%	-1.3%
Net Profit Qtr	46.87	4.65	340.27	908.0%	-86.2%
Earning Per Share Adjusted latest Qtr	1.66	0.16	12.06	937.5%	-86.2%